NCT06623942Completed
Prostasin Levels in Preeclamptic Women
Prostasin Levels in Preeclampsia: A Comparative Study With Healthy Pregnancies
Source: ClinicalTrials.gov · Last updated 2 Oct 2024
Brief summary (registry, in English)
This study will aim to compare maternal serum prostasin levels between women diagnosed with preeclampsia and healthy normotensive pregnant controls. Participants will be divided into two main groups: those with preeclampsia and those with uncomplicated pregnancies. The preeclampsia group will further be subdivided based on the severity of the condition. Maternal serum samples will be collected from all participants, and prostasin levels will be measured using ELISA. Statistical analyses will be performed to evaluate whether prostasin levels are significantly elevated in the preeclampsia group, particularly in those with severe features, and to assess its potential as a biomarker for the condition.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 88 (actual)
- First submitted
- 24 Sept 2024
- Start date
- 1 Jan 2023
- Primary completion date
- 1 Jan 2024
- Lead sponsor
- Başakşehir Çam & Sakura City Hospital
- NCT number
- NCT06623942
What you commit to
- Study type: Observational
- Participants enrolled: 88
- From 1 Jan 2023 to the primary completion date, 1 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Pregestational Diabetes
- Chronic Hypertension
- Systemic Diseases (Chronic kidney disease, autoimmune diseases)
Other
- Multiple Pregnancies
- Fetal Anomalies
- Premature Rupture of Membranes.
Who the study is looking for
- Diagnosis of Preeclampsia: Defined by new-onset hypertension (systolic Blood Pressure ≥140 mmHg and/or diastolic Blood Pressure ≥90 mmHg) after 20 weeks of gestation, with or without proteinuria.
- Control Group: Healthy pregnancies without preeclampsia or other significant maternal or fetal complications.
Age in the registry: 18 years to 40 years · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cam and Sakura City Hospital Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.